|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,168.50 JPY | -0.34% |
|
-1.88% | +3.61% |
| 13/07 | Pfizer, Astellas Secure FDA Nod For Bladder Cancer Drug | MT |
| 11/07 | Health Care Down on Rotation Back to Tech - Health Care Roundup | DJ |
| Market Cap | 3,88500Cr 2.47TCr 2.14TCr 2TCr 1.83TCr 3.47TCr 2,34500Cr 3.51TCr 24TCr 9.2TCr 1,17200Cr 9.26TCr 9.06TCr | P/E 2027 * |
11.3x | P/E 2028 * | 11.7x |
|---|---|---|---|---|---|
| Enterprise Value | 3,75500Cr 2.38TCr 2.07TCr 1.93TCr 1.77TCr 3.35TCr 2,26700Cr 3.39TCr 23TCr 8.89TCr 1,13300Cr 8.95TCr 8.75TCr | EV / Sales 2027 * |
1.66x | EV / Sales 2028 * | 1.64x |
| Free-Float |
97.66% | Yield 2027 * |
3.7% | Yield 2028 * | 3.82% |
Last Transcript: Astellas Pharma Inc.
| 1 day | -0.34% | ||
| 1 week | -1.88% | ||
| Current month | -1.52% | ||
| 1 month | +0.77% | ||
| 3 months | -1.74% | ||
| 6 months | -2.45% | ||
| Current year | +3.61% |
| 1 week | 2,125 |  | 2,305.5 |
| 1 month | 2,109 | | 2,305.5 |
| Current year | 2,041 | | 2,717 |
| 1 year | 1,552 | | 2,717 |
| 3 years | 1,243.5 | | 2,717 |
| 5 years | 1,243.5 | | 2,717 |
| 10 years | 1,243.5 | | 2,717 |
| Manager | Title | Age | Since |
|---|---|---|---|
Naoki Okamura
CEO | Chief Executive Officer | 63 | 10/02/2023 |
Kitamura Atsushi
DFI | Director of Finance/CFO | 54 | 01/11/2023 |
Tatjana Dragovic
CMP | Compliance Officer | - | 01/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kenji Yasukawa
CHM | Chairman | 66 | 10/02/2023 |
Naoki Okamura
BRD | Director/Board Member | 63 | 01/06/2019 |
| Director/Board Member | 58 | 01/06/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.34% | -1.88% | +37.55% | +7.83% | 2.49TCr | |
| -0.75% | -8.55% | +45.17% | +148.35% | 1LCr | |
| -0.20% | -4.89% | +48.32% | +50.08% | 61TCr | |
| -0.62% | -7.76% | +23.12% | +64.34% | 43TCr | |
| +0.48% | -2.77% | +40.27% | +34.96% | 35TCr | |
| +0.08% | -4.45% | +31.74% | +39.89% | 29TCr | |
| +2.09% | -9.27% | +5.42% | +7.61% | 24TCr | |
| +1.75% | -8.29% | -1.73% | -42.05% | 21TCr | |
| +2.61% | -1.27% | +28.54% | +59.54% | 20TCr | |
| +0.69% | -1.68% | +15.33% | +67.84% | 16TCr | |
| Average | +0.60% | -3.65% | +27.37% | +43.84% | 35.25TCr | |
| Weighted average by Cap. | +0.16% | -4.32% | +33.58% | +70.17% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 2,26000Cr 1.43TCr 1.25TCr 1.16TCr 1.07TCr 2.02TCr 1,36400Cr 2.04TCr 14TCr 5.35TCr 68TCr 5.39TCr 5.27TCr | 2,07900Cr 1.32TCr 1.15TCr 1.07TCr 981.37Cr 1.86TCr 1,25500Cr 1.88TCr 13TCr 4.92TCr 63TCr 4.96TCr 4.85TCr |
| Net income | 34TCr 217.41Cr 188.77Cr 176.01Cr 161.69Cr 305.79Cr 21TCr 309.15Cr 2.08TCr 811.18Cr 10TCr 816.42Cr 798.53Cr | 33TCr 209.94Cr 182.29Cr 169.96Cr 156.13Cr 295.29Cr 20TCr 298.53Cr 2TCr 783.31Cr 9.98TCr 788.37Cr 771.09Cr |
| Net Debt | -13TCr -83Cr -72Cr -67Cr -61Cr -116.12Cr -7.85TCr -117.4Cr -787.98Cr -308.04Cr -3.93TCr -310.03Cr -303.23Cr | -47TCr -299.77Cr -260.29Cr -242.69Cr -222.95Cr -421.65Cr -29TCr -426.27Cr -2.86TCr -1.12TCr -14TCr -1.13TCr -1.1TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/26/04 | JP¥2,168.50 | -0.34% | 67,19,900 |
| 03/26/03 | JP¥2,176.00 | -1.18% | 73,73,300 |
| 31/26/31 | JP¥2,202.00 | -3.72% | 82,29,600 |
| 30/26/30 | JP¥2,287.00 | -0.37% | 85,31,100 |
| 29/26/29 | JP¥2,295.50 | +2.78% | 93,94,300 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4503 Stock
Select your edition
All financial news and data tailored to specific country editions
